Dr. Ana Gubeladze, MD

Dr. Gubeladze practices at Los Angeles General Medical Center in Los Angeles, California.

Dr. Gubeladze's NPI, 1912430554, was assigned on April 11, 2017. Dr. Gubeladze graduated from "Aieti" Highest Medical School in 2014. Dr. Gubeladze's Texas license number on file is T2615.

Dr. Gubeladze's primary practice is Los Angeles General Medical Center, at 2051 Marengo St, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 409-2800.

Dr. Gubeladze's primary practice is Los Angeles General Medical Center in Los Angeles, California. Dr. Gubeladze is also affiliated with University Hospital. The medical group on file is University Medicine Associates. Dmand AI also links Dr. Gubeladze to 5 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gubeladze practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gubeladze's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Gubeladze is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Gubeladze's licenses on file in 3 states: Texas, Florida and New Jersey.

Dmand AI lists atherosclerosis, cardiac arrhythmia, chronic kidney disease, circulation problems, collapsed lung, congestive heart failure, gastrointestinal bleeding and heart attack among the conditions Dr. Gubeladze treats.

CMS data shows 789 Medicare services from Dr. Gubeladze across 4 procedure codes in 2024, for 347 Medicare patients. Medicare paid $68,922 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 347 Medicare patients who saw Dr. Gubeladze in 2024. The largest group is 75 to 84, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gubeladze's median patient age at 68, with 49% women.

In 2024, Dr. Gubeladze wrote 444 Medicare Part D claims for 169 patients. 90% of them were for generic drugs. CMS names the drug for 197 of them, across 11 drugs with 11 or more claims each, at $7,228 in total drug cost. In 2023, CMS named 161 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Gubeladze for performance year 2024, reported as part of a group. Dr. Gubeladze accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Gubeladze in 2019. Dr. Gubeladze's most frequent co-authors are Soemiwati Weidris Holland, MD and Rabail S. Soomro, MD.

CMS Open Payments shows 24 general payments to Dr. Gubeladze from 8 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $153.

Dr. Gubeladze graduated from "Aieti" Highest Medical School in 2014.

Dr. Gubeladze is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.